×
模态框（Modal）标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框（Modal）标题
×
Toggle navigation
Journal of Southern Medical University
Home
About journal
About Journal
Editorial board
Issue
Issue catalogue
Accepted
Current issue
E-mail Alert
News
For authors
Guidelines for English Manuscript Submission
Conflict of Interest Statement
Editorial Policies and Peer Review Process
Open Access, Copyright and License Notices
Contact us
中文
Gefitinib versus Erlotinib as first-line treatment for patients with advanced EGFR
mutation-positive non-small-cell lung cancer
谢亚琳，梁继珍，苏宁
Journal of Southern Medical University . 2015, (
03
): 446 .
